Pay in 4 interest-free payments of $5.73 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Specific Populations Pharmacokinetics of tesamorelin in patients with renal or hepatic impairment, in pediatric patients, or in elderly patients has not been established
4 For patients with an entry A1C of 7.5% or higher, the algorithm recommends dual therapy consisting of metformin plus an additional antihyperglycemic agent
Ipamorelin is a synthetic pentapeptide growth hormone secretagogue, studied for its selective stimulation of growth hormone release via ghrelin receptor (GHS-R1a) activation without significantly impacting cortisol or prolactin levels
Individual results depend on starting weight, protocol adherence, and metabolic health
Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: a meta-analysis of randomised clinical trials
US$ 26.59
US$ 28.43
US$ 29.14
US$ 24.39
